Apimeds Pharmaceuticals US, Inc. (APUS) stock
APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.95−0.09 (-4.41%)
Close on Nov 17, 2026Market cap $2.94MP/E –Yield –
Apimeds Pharmaceuticals US gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?